Literature DB >> 6751438

Allogeneic marrow transplantation for chronic granulocytic leukemia.

B Speck, A Gratwohl, C Nissen, B Osterwalder, M Müller, P Bannert, H Müller, M Jeannet.   

Abstract

Six patients with Philadelphia-chromosome (Ph' +)-positive chronic granulocytic leukemia were transplanted from their HLA-identical siblings after conditioning with cyclophosphamide and 1'000 rad total body irradiation. All received cyclosporin-A for prophylaxis of Graft-versus-Host disease. All patients showed prompt engraftment and all are cytogenetically and clinically in complete remission. Two patients had transient mild signs of Graft-versus-Host-disease and one patient had unilateral facial nerve paresis of unknown origin. All are ambulatory and well 6-18 months (median 10 months) after transplantation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751438     DOI: 10.1007/bf00320190

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors:  E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

2.  Modern approaches to the management of chronic granulocytic leukemia.

Authors:  J M Goldman
Journal:  Semin Hematol       Date:  1978-10       Impact factor: 3.851

3.  Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow.

Authors:  C D Buckner; P Stewart; R A Clift; A Fefer; P E Neiman; J Singer; R Storb; E D Thomas
Journal:  Exp Hematol       Date:  1978-01       Impact factor: 3.084

4.  Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).

Authors:  I Cunningham; T Gee; M Dowling; R Chaganti; R Bailey; S Hopfan; L Bowden; A Turnbull; W Knapper; B Clarkson
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

5.  Splenectomy in chronic myeloid leukemia.

Authors:  D J Wolf; R T Silver; M Coleman
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

Review 6.  Chronic myelogenous leukemia--new concepts (first of two parts).

Authors:  H P Koeffler; D W Golde
Journal:  N Engl J Med       Date:  1981-05-14       Impact factor: 91.245

7.  Treatment of chronic granulocytic leukemia by chemotherapy, total body irradiation and allogeneic bone marrow transplantation.

Authors:  K Doney; C D Buckner; G E Sale; R Ramberg; C Boyd; E D Thomas
Journal:  Exp Hematol       Date:  1978-10       Impact factor: 3.084

8.  Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.

Authors:  R L Powles; H M Clink; D Spence; G Morgenstern; J G Watson; P J Selby; M Woods; A Barrett; B Jameson; J Sloane; S D Lawler; H E Kay; D Lawson; T J McElwain; P Alexander
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321

9.  Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins.

Authors:  A Fefer; M A Cheever; P D Greenberg; F R Appelbaum; C N Boyd; C D Buckner; H G Kaplan; R Ramberg; J E Sanders; R Storb; E D Thomas
Journal:  N Engl J Med       Date:  1982-01-14       Impact factor: 91.245

10.  Allogeneic bone marrow transplantation for chronic granulocytic leukemia.

Authors:  K C Doney; C D Buckner; E D Thomas; J Sanders; R A Clift; J A Hansen; G E Sale; J Singer; R Storb
Journal:  Exp Hematol       Date:  1981-11       Impact factor: 3.084

View more
  2 in total

1.  Bone marrow transplantation beyond treatment of aplasia and neoplasia.

Authors:  E Beutler
Journal:  West J Med       Date:  1994-02

2.  Bone marrow transplantation for chronic granulocytic leukaemia.

Authors:  H K Mahmoud; U W Schaefer; F Schüning; D Beelen; R Becher; C G Schmidt; W Alberti; E Haralambie; G Linzenmeier; B Stollmann
Journal:  Klin Wochenschr       Date:  1985-06-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.